Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-04-08
2008-04-08
Mondesi, Robert (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
10516450
ABSTRACT:
A method and composition for inhibiting or slowing blood coagulation includes lactadherin, a fragment of lactadherin, a functional equivalent of lactadherin, or a functional equivalent of a fragment of lactadherin.
REFERENCES:
patent: 4725442 (1988-02-01), Haynes
patent: 5120537 (1992-06-01), Esmon et al.
patent: 5258497 (1993-11-01), Reutelingsperger et al.
patent: 5344758 (1994-09-01), Krilis et al.
patent: 5455031 (1995-10-01), Ceriani et al.
patent: 5505955 (1996-04-01), Peterson et al.
patent: 5632986 (1997-05-01), Tait et al.
patent: 5667797 (1997-09-01), Peterson et al.
patent: 5783662 (1998-07-01), Janmey et al.
patent: 5846743 (1998-12-01), Janmey et al.
patent: 5849600 (1998-12-01), Nixon et al.
patent: 5874409 (1999-02-01), Victoria et al.
patent: 5955437 (1999-09-01), Reutelingsperger
patent: 5972337 (1999-10-01), Ceriani et al.
patent: 6194214 (2001-02-01), Kraus
patent: 6284475 (2001-09-01), Rand
patent: 6312694 (2001-11-01), Thorpe et al.
patent: 6410775 (2002-06-01), Victoria et al.
patent: 2003/0022221 (2003-01-01), Langit et al.
patent: 2004/0197314 (2004-10-01), Delcayre et al.
patent: 2004/0241179 (2004-12-01), Raposo et al.
patent: 1004664 (2000-05-01), None
patent: WO 00/30667 (2000-06-01), None
patent: WO2005/005954 (2005-01-01), None
Aoki et al., “Stage specific expression of milk fat globule membrane glycoproteins in mouse mammary gland: comparison of MFG-E8, butyrophilin, and CD36 with a major milk protein, beta casein”, Biochimica et Biophysica Acta 1334: 182-190 (1997).
Shi et al., “Lactadherin binds selectively to membrane containing phosphatidyl-L-serine and increased curvature”, Biochimica et Biophysica Acta 1667: 82-90 (2004).
Ortel et al.Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J. Biol. Chem. Feb. 25, 1992, vol. 267, No. 6, pp. 4189-4198.
Larocca et al.A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res. Sep. 15, 1991, vol. 51, No. 18, pp. 4994-4998.
Ortel et al.Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity. J. Clin. Invest. Dec. 1992, vol. 90, pp. 2340-2347.
Hvarregaard J, Andersen MH, Berglund L, Rasmussen JT,Petersen TE. Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur J Biochem. 1996;240:628-636.
Stubbs J, Lekutis C, Singer K, et al. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidemal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci, USA. 1990;87:8417-8421.
Couto JR, Taylor MR, Godwin SG, Ceriani RL,Peterson JA. Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell Biol. 1996;15:281-286.
Andersen MH, Berglund L, Rasmussen JT,Petersen TE. Bovine PAS-6/7 binds avb5integrin and anionic phospholipids through two domains. Biochem. 1997;36:5441-5446.
Taylor MR, Couto JR, Scallan CD, Ceriani RL, Peterson JA. Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell Biol. 1997;16:861-869.
Andersen MH, Graversen H, Fedosov SN, Petersen TE,Rasmussen JT. Functional analyses of two cellular binding domains of bovine lactadherin. Biochem. 2000;39:6200-6206.
Butler JE, Pringnitz DJ, Martens CL,Crouch N. Bovine-associated mucoprotein: I. Distribution among adult and fetal bovine tissues and body fluids. Differentiation. 1980;17:31-40.
Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet. 1998;351:1160-1164.
Peterson JA, Couto JR, Taylor MR,Ceriani RL. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer. Cancer Res. 1995;55:5847s-5851s.
Haggqvist B, Naslund J, Sletten K, et al. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad U S A. 1999;96:8669-8674.
Ensslin M, Calvete JJ, Thole HH, et al. Identification by affinity chromatography of boar sperm membrane- associated proteins bound to immobilized porcine zona pellucida. Mapping of the phosphorylethanolamine-binding region of spermadhesin AWN. Biol Chem Hoppe Seyler. 1995;376:733-738.
Arai M, Scandella D,Hoyer L. Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J Clin Invest. 1989;83:1978-1984.
Foster PA, Fulcher CA, Houghten RA,Zimmerman TS. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood. 1990;75:1999-2004.
Ortel T, Devore-Carter D, Quinn-Allen M,Kane W. Deletion analysis of recombinant human factor V: Evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem. 1992;267:4189-4198.
Gilbert GE, Furie BC,Furie B. Binding of human factor VIII to phospholipid vesicles. J Biol Chem. 1990;265:815-822.
Gilbert GE, Drinkwater D, Barter S,Clouse SB. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII: Studies with model membranes supported by glass microspheres (Lipospheres). J Biol Chem. 1992;267:15861-15868.
Gilbert GE,Drinkwater D. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. Biochem. 1993;32:9577-9585.
Comfurius P, Smeets EF, Willems GM, Bevers EM,Zwaal RFA. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. Biochem. 1994;33:10319-10324.
Gilbert GE,Arena AA. Phosphatidylethanolamine induces high affinity binding sites for factor VIII on membranes containing phosphatidyl-L-serine. J Biol Chem. 1995;270:18500-18505.
Gilbert GE,Arena AA. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII. Biochem. 1998;37:13526-13535.
Pratt KP, Shen BW, Takeshima K, et al. Structure of the C2 domain of human factor VIII at 1.5 angstrom resolution. Nature. 1999;402:439-442.
Macedo-Ribeiro S, Bode W, Huber R, et al. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature. 1999;402:434-439.
Kim SW, Quinn-Allen, MA, Camp JT, et al. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis. Biochem. 2000;39:1951-1958.
Peterson JA, Patton S,Hamosh M. Glycoproteins of the human milk fat globule in the protection of the breast-fed infant against infections. Biol Neonate. 1998;74:143-162.
Tait JF, Gibson D,Fujikawa K. Phospholipid binding properties of human placental anticoagulent protein-1, a member of the lipocortin family. J Biol Chem. 1989;264:7944-7949.
Crompton MR, Moss SE,Crumpton MJ. Diversity in the lipocortin/calpactin family. Cell. 1988;55:1-3.
Swairjo MA, Concha NO, Kaetzel MA, Dedman JR,Seaton BA. Ca2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nat Struct Biol. 1995;2:968-974.
Tait JF, Sakata MS, McMullen BA, et al. Placental anticoagulent proteins: Isolation and comparative characterization of four members of the lipocortin family. Biochem. 1988;27:6268-6276.
Gilbert GE,Arena AA. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. J Biol Chem. 1996;271-11120-11125.
Bangham AD, Standish MM,Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238-252.
Johnson SM, Bangham AD, Hill MW,Korn ED. Single bilayer liposomes. Bioc
Gilbert Gary E.
Shi Jialin
Brigham & Women's Hospital Inc.
Desai Anand
Dinesh Agarwal, P.C.
Mondesi Robert
The United States of America as represented by the Department of
LandOfFree
Method and composition for inhibiting or slowing blood... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for inhibiting or slowing blood..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for inhibiting or slowing blood... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3918062